[Overview]

The EXOS formulation used in eye drop therapy contains exosomes derived from human dental pulp stem cells, which are approximately 100 nm in size. This size is expected to provide high corneal permeability, allowing for the activation of corneal epithelium and improvement of eye functions, including:

  1. Enhancing weakened accommodation ability.
  2. Moisturizing dry eyes.
  3. Supplementing nutrients to the eyes and promoting tissue metabolic functions.

These benefits make it a promising option for addressing Digital Eye Strain.

"Eyedrop Exosome for Eye Frailty Prevention"

When the eyes deteriorate with age, various external stresses can lead to a state of decreased eye function, which is referred to as "eye frailty." As aging progresses, the structure and functionality of the eyeball decline in various ways. This condition becomes a significant stressor and can impair visual function. Initially, it may be asymptomatic, but at times, one may experience difficulty seeing or discomfort. If left untreated, this condition further deteriorates, leading to a constant awareness of decreased vision, which can cause significant stress throughout the body. Early prevention and treatment can help slow the progression and alleviate symptoms.